Insider Transactions in Q3 2024 at Sagimet Biosciences Inc. (SGMT)
Insider Transaction List (Q3 2024)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Jul 23
2024
|
George Kemble Executive Chairman |
SELL
Open market or private sale
|
Direct |
23,625
-16.6%
|
$70,875
$3.17 P/Share
|
Jul 19
2024
|
George Kemble Executive Chairman |
SELL
Open market or private sale
|
Direct |
14,062
-8.99%
|
$42,186
$3.1 P/Share
|
Jul 19
2024
|
Elizabeth Rozek General Counsel and CCO |
SELL
Open market or private sale
|
Direct |
10,914
-6.37%
|
$32,742
$3.1 P/Share
|
Jul 19
2024
|
Eduardo Bruno Martins Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
8,357
-9.33%
|
$25,071
$3.1 P/Share
|